REFERENCES
  1. Gudjonsson, J. E., and Elder, J. T. 2007. Psoriasis: epidemiology. Clin Dermatol 25:535-546.
  2. Rademaker, M., Agnew, K., Anagnostou, N., Andrews, M., Armour, K., Baker, C., Foley, P., Gebauer, K., Gupta, M., Marshman, G., and Rubel, D. 2019. Psoriasis and infection. A clinical practice narrative. Australas J Dermatol 60:91-98.
  3. Zampetti, A., Gnarra, M., Linder, D., Digiuseppe, M.D., Carrino, N., and Feliciani, C. 2010. Psoriatic pseudobalanitis circinata as a post-viral Koebner phenomenon. Case Rep Dermatol 2:183-188.
  4. Fry, L., and Baker, B.S., 2007. Triggering psoriasis: the role of infections and medications. Clin Dermatol 25:606-615.
  5. Favre, M., Orth, G., Majewski, S., Pura, A., Jablonska, S., and Baloul, S. 1998. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 110:311-317.
  6. Wolf, P., Seidl, H., Bäck, B., Binder, B., Höfler, G., Quehenberger, F., Hoffmann, C., Kerl, H., Stark, S., Pfister, H.J., and Fuchs, P.G. 2004. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A. Arch Dermatol 140:317-324.
  7. Handisurya, A., Lázár, S., Papay, P., Primas, C., Haitel, A., Horvat, R., Tanew, A., Vogelsang, H., and Kirnbauer, R. 2016. Anogenital human papillomavirus prevalence is unaffected by therapeutic tumour necrosis factor-alpha inhibition. Acta Derm Venereol 96:494-498.
  8. Carnero, L., González-Pérez, R., Arrue, I., and Soloeta, R. 2011. Multiple warts appearing exclusively on psoriasis plaques. Actas Dermosifiliogr 102:835-836.
  9. Majewski, S., Jablonska, S., Favre, M., and Orth, G. 2001. Cytokines may favor a role for human papillomaviruses in the pathogenesis of psoriasis. Arch Dermatol 137:1373.
  10. de Villiers, E.M., and Ruhland, A., 2001. Do specific human papillomavirus types cause psoriasis? Arch. Dermatol 137:384.